Frank Schäfer

Title: Frank Schäfer: Innovator in Renin Inhibitor Synthesis

Introduction

Frank Schäfer is a notable inventor based in Rheinfelden-Adelhausen, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the synthesis of renin inhibitors. His innovative work has led to the development of processes that enhance the production of vital pharmaceutical compounds.

Latest Patents

Frank Schäfer holds a patent for a process for preparing renin inhibitors. This invention provides a novel process, novel process steps, and novel intermediates useful in the synthesis of pharmaceutically active compounds, especially renin inhibitors such as Aliskiren. The patent outlines a method for manufacturing a compound of a specific formula, involving the reaction of a compound with a reagent that transforms hydroxy into a leaving group.

Career Highlights

Throughout his career, Frank Schäfer has worked with prominent companies in the pharmaceutical industry, including Novartis AG and Novartis Pharma GmbH. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking advancements in drug synthesis.

Collaborations

Frank has collaborated with esteemed colleagues such as Stuart J Mickel and Gottfried Sedelmeier. These partnerships have fostered an environment of innovation and have led to the successful development of new pharmaceutical processes.

Conclusion

Frank Schäfer's contributions to the field of pharmaceutical innovation, particularly in the synthesis of renin inhibitors, highlight his role as a significant inventor. His work continues to impact the pharmaceutical industry positively.